Skip to Main Content

End-Stage Renal Disease and Clinical Laboratories Open Door Forum


The End Stage Renal Disease (ESRD) and Clinical Laboratories Open Door Forum (ODF) addresses the concerns of the renal care and lab service communities in relation to the Medicare & Medicaid programs. Payment, billing and coverage issues are all handled in the discussions, as well as specifics within CLIA, the Fistula First Initiative and ESRD-related provisions of the Physician Fee Schedule (PFS) and the Medicare Modernization Act (MMA). Timely announcements and clarifications regarding important rulemaking, agency program initiatives and other related areas are also included in the forums.

To receive notice when the next End Stage Renal Disease (ESRD) & Clinical Laboratories Open Door Forum is scheduled, please refer to the "Related Links" section below to sign up on the Mailing List.

**Updated: January 27, 2015 - Special Open Door Forum (SODF): Understanding Dialysis Facility Compare-Driving Informed Decision Making, Wednesday, February 4, 2015, from 2:00 p.m. – 3:00p.m. Eastern Time. The purpose of this SODF call is allow patient advocacy groups, dialysis patients, and other interested parties to provide information and to solicit feedback on the introduction of star ratings on Dialysis Facility Compare. This Special Open Door Forum will provide background on the Compare website star rating initiative, the development of star ratings for DFC, and the role of star ratings and other important consumer information in making treatment decisions. We invite questions from ESRD patients, consumers and consumer advocates, and plans, providers, and purchasers in advance, or during the forum. Please submit questions here. Please follow along during the call for the Power Point slides:   If you wish to participate, dial: 1-800-837-1935 & Conference ID: 62054250.  We look forward to your participation. Please see the Downloads section below for the full call announcement. Thank you for your continued interest in the CMS Open Door Forums.